Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04885504 · ClinicalTrials.gov registry record
Post COVID-19 Biorepository
A clinical trial of Corona Virus Infection, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04885504: Recruiting study of Corona Virus Infection, sponsored by University of Kansas Medical Center.
NCT04885504 is a study of Corona Virus Infection that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 100 participants, below the 582-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04885504, a study of Corona Virus Infection, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.
Primary Outcome
Establish a collection of biospecimens from patients who have recovered from COVID-19.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2026-07-15 |
What NCT04885504 shows while recruiting
NCT04885504 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 582-participant average among 28 other Corona Virus Infection trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Corona Virus Infection appearing as the primary indexed condition, and to 0 interventions.
NCT04885504 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT04885504 about?
NCT04885504 is a clinical study titled "Post COVID-19 Biorepository". Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.
What is the current status of trial NCT04885504?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-02-08. Estimated completion is 2026-07-15.
What conditions does trial NCT04885504 study?
This clinical trial studies the following conditions: Corona Virus Infection.
Who is sponsoring clinical trial NCT04885504?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04885504 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corona Virus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04885504's enrollment target sits among peer trials
100 19th of 28 higher than 10 of 28 other Corona Virus Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Corona Virus Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
RECRUITING
-
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
RECRUITING
-
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
RECRUITING
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
KIDney Injury in Times of COVID-19 (KIDCOV)
RECRUITING
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI